2017
SYNTHESIS AND AMINOPEPTIDASE N INHIBITING ACTIVITY OF 3-(NITROPHENOXYMETHYL)-[1,3,2]DIOXABOROLAN-2-OLS AND THEIR OPEN ANALOGUES
FARSA, Oldřich, Jakub KÁŇA, Irena MACKŮ, Jana ŽELAZKOVÁ, Jana PODLIPNÁ et. al.Základní údaje
Originální název
SYNTHESIS AND AMINOPEPTIDASE N INHIBITING ACTIVITY OF 3-(NITROPHENOXYMETHYL)-[1,3,2]DIOXABOROLAN-2-OLS AND THEIR OPEN ANALOGUES
Autoři
FARSA, Oldřich (203 Česká republika, garant, domácí), Jakub KÁŇA, Irena MACKŮ (203 Česká republika), Jana ŽELAZKOVÁ (203 Česká republika), Jana PODLIPNÁ, Aleš CIRKVA, Jaroslav MAXA a Kamil ŠŤASTNÝ
Vydání
ACTA POLONIAE PHARMACEUTICA, WARSAW, POLSKIE TOWARZYSTWO FARMACEUTYCZNE, 2017, 0001-6837
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30104 Pharmacology and pharmacy
Stát vydavatele
Polsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 0.531
Kód RIV
RIV/00216224:14160/17:00120955
Organizační jednotka
Farmaceutická fakulta
UT WoS
000410257700014
Klíčová slova anglicky
aminopeptidase N/CDI3; dioxaborolanols; phenoxypropandiols; inhibitory activity; anticancer activity; antiviral activity; lipophilicity; QSAR
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 10. 8. 2021 09:03, doc. PharmDr. Oldřich Farsa, Ph.D.
Anotace
V originále
Aminopeptidase N (APN) represents a class of zinc metallopeptidases with broad substrate specifity. This enzyme is involved in control of angioneogenesis in cancer and microvascular conditions. It also serves as a superficial cellular receptor that enables attachment of some viruses including coronaviruses to the host cell. APN takes part also in metabolism of some important neuropeptides. That is why APN can be a promising therapeutic target and compounds which influence its activity interesting potential drugs. Here, synthesis of compounds which in most contain 3-phenoxypropan-1,2 diol moiety and evaluation of their inhibition activity against APN is described. 4-[1-, 2- and 3-(Nitrophenoxymethyl)]-[1,3,2]dioxaborolan-2-ols are novel compounds which have never been previously reported in the literature. 3-(Aminophenoxy)propyl-1,2-diols revealed greater activity than both 3-(nitrophenoxy)propyl-1,2-diols and 3-(nitrophenoxymethyl)-[1,3,2]dioxaborolan-2-ols. A QSAR study revealed a linear correlation between lipophilicity and inhibition activity.